Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra Kutzelnigg

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Journal of the Neurological Sciences|May 3, 2006
Cortical demyelination in multiple sclerosis: a substrate for cognitive deficits?Alexandra Kutzelnigg, Hans Lassmann
Handbook of Clinical Neurology|February 11, 2014
Pathology of multiple sclerosis and related inflammatory demyelinating diseasesAlexandra Kutzelnigg, Hans Lassmann
Journal of the Neurological Sciences|May 17, 2005
Cortical lesions and brain atrophy in MSAlexandra Kutzelnigg, Hans Lassmann
Neuropsychiatric Disease and Treatment|July 14, 2011
Improvement of the noradrenergic symptom cluster following treatment with milnacipranSiegfried Kasper, Diana Meshkat, Alexandra Kutzelnigg
Current Medical Research and Opinion|June 8, 2013
Attention deficit hyperactivity disorder in the European adult population: prevalence, disease awareness, and treatment guidelinesJosep Antoni Ramos-Quiroga, Alonso Montoya, Alexandra Kutzelnigg, et al.
Annals of Neurology|October 11, 2007
Multiple sclerosis and Alzheimer's diseaseAssunta Dal Bianco, Monika Bradl, Josa Frischer, et al.
Journal of Assisted Reproduction and Genetics|May 31, 2002
Ascorbic acid supplement during luteal phase in IVFGeorg Griesinger, Katharina Franke, Cordelia Kinast, et al.
Child and Adolescent Psychiatry and Mental Health|May 8, 2013
Baseline characteristics of European and non-European adult patients with attention deficit hyperactivity disorder participating in a placebo-controlled, randomized treatment study with atomoxetineHimanshu Upadhyaya, Lenard A Adler, Miguel Casas, et al.
Brain : a Journal of Neurology|October 19, 2005
Cortical demyelination and diffuse white matter injury in multiple sclerosisAlexandra Kutzelnigg, Claudia F Lucchinetti, Christine Stadelmann, et al.
The Lancet. Neurology|August 24, 2010
Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trialMurat Emre, Magda Tsolaki, Ubaldo Bonuccelli, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Journal of the Neurological Sciences|May 3, 2006
Cortical demyelination in multiple sclerosis: a substrate for cognitive deficits?Alexandra Kutzelnigg, Hans Lassmann
Handbook of Clinical Neurology|February 11, 2014
Pathology of multiple sclerosis and related inflammatory demyelinating diseasesAlexandra Kutzelnigg, Hans Lassmann
Journal of the Neurological Sciences|May 17, 2005
Cortical lesions and brain atrophy in MSAlexandra Kutzelnigg, Hans Lassmann
Neuropsychiatric Disease and Treatment|July 14, 2011
Improvement of the noradrenergic symptom cluster following treatment with milnacipranSiegfried Kasper, Diana Meshkat, Alexandra Kutzelnigg
Current Medical Research and Opinion|June 8, 2013
Attention deficit hyperactivity disorder in the European adult population: prevalence, disease awareness, and treatment guidelinesJosep Antoni Ramos-Quiroga, Alonso Montoya, Alexandra Kutzelnigg, et al.
Annals of Neurology|October 11, 2007
Multiple sclerosis and Alzheimer's diseaseAssunta Dal Bianco, Monika Bradl, Josa Frischer, et al.
Journal of Assisted Reproduction and Genetics|May 31, 2002
Ascorbic acid supplement during luteal phase in IVFGeorg Griesinger, Katharina Franke, Cordelia Kinast, et al.
Child and Adolescent Psychiatry and Mental Health|May 8, 2013
Baseline characteristics of European and non-European adult patients with attention deficit hyperactivity disorder participating in a placebo-controlled, randomized treatment study with atomoxetineHimanshu Upadhyaya, Lenard A Adler, Miguel Casas, et al.
Brain : a Journal of Neurology|October 19, 2005
Cortical demyelination and diffuse white matter injury in multiple sclerosisAlexandra Kutzelnigg, Claudia F Lucchinetti, Christine Stadelmann, et al.
The Lancet. Neurology|August 24, 2010
Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trialMurat Emre, Magda Tsolaki, Ubaldo Bonuccelli, et al.
Pageof 3